Memantine (Namenda) for neuropathic pain.

  title={Memantine (Namenda) for neuropathic pain.},
  author={Mailien Rogers and Atif Rasheed and Abdolali Moradimehr and Steven J Baumrucker},
  journal={The American journal of hospice & palliative care},
  volume={26 1},
Neuropathic pain is common in the palliative care population; unless adequately treated, the pain can lead to chronic anxiety, depression, and social impairment. Many treatments have been proposed for neuropathic pain; however, it remains underdiagnosed, under-treated, and often requires long-term therapy with risk of adverse effects. Memantine (Namenda), an N-Methyl, D-aspartate receptor inhibitor currently marketed for the treatment of dementia, has been proposed as a medication for the… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS

From This Paper

Figures, tables, results, connections, and topics extracted from this paper.
6 Extracted Citations
26 Extracted References
Similar Papers

Referenced Papers

Publications referenced by this paper.
Showing 1-10 of 26 references

Diagnosis and treatment of neuropathic pain

  • MS Wallace
  • Curr Opin Anaesthesiol
  • 2005
1 Excerpt

Similar Papers

Loading similar papers…